Our business development model is built on a multi-pronged approach, combining mergers and acquisitions, in-licensing, and a contract sales organization (CSO) model. This approach enables us to continue expanding our portfolio and commercialization footprint while strengthening our presence and competitive edge in core therapeutic areas.